Nikkei covered Craif's next-generation laboratory system in its digital edition on September 18, 2026

TOKYO, September 24, 2026 - Nikkei covered Oyster Lab OS, Craif Inc.'s next-generation laboratory system, in its digital edition on September 18, 2026.

Coverage details

• Published: September 18, 2026
• Outlet: Nikkei, digital edition
• Headline (working English translation): "Cancer test kit maker Craif to sell its lab management know-how to outside customers"
• Article: https://www.nikkei.com/article/DGXZQOUC17A3J0X10C26A9000000/

About Craif

Craif is a bio-AI company founded in 2018 that develops non-invasive tests for the early detection of cancer. Its platform combines proprietary biomarker detection from urine and other bodily fluids with AI to assess disease risk. Building on one of the world's largest urine datasets, Craif aims to create a urine analysis platform that detects a wide range of diseases early, with cancer as the first step. The company is based in Tokyo and operates a wholly owned laboratory in San Diego, opened in 2026. Learn more at craif.com.

Media inquiries
press_us@craif.com